JP2013505011A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505011A5
JP2013505011A5 JP2012529337A JP2012529337A JP2013505011A5 JP 2013505011 A5 JP2013505011 A5 JP 2013505011A5 JP 2012529337 A JP2012529337 A JP 2012529337A JP 2012529337 A JP2012529337 A JP 2012529337A JP 2013505011 A5 JP2013505011 A5 JP 2013505011A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
process according
cells
medium
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012529337A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013505011A (ja
Filing date
Publication date
Priority claimed from GBGB0916370.0A external-priority patent/GB0916370D0/en
Application filed filed Critical
Publication of JP2013505011A publication Critical patent/JP2013505011A/ja
Publication of JP2013505011A5 publication Critical patent/JP2013505011A5/ja
Withdrawn legal-status Critical Current

Links

JP2012529337A 2009-09-18 2010-09-16 幹細胞馴化培地組成物 Withdrawn JP2013505011A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0916370.0A GB0916370D0 (en) 2009-09-18 2009-09-18 Compositions
GB0916370.0 2009-09-18
PCT/GB2010/001739 WO2011033260A1 (en) 2009-09-18 2010-09-16 Stem cell conditioned medium compositions

Publications (2)

Publication Number Publication Date
JP2013505011A JP2013505011A (ja) 2013-02-14
JP2013505011A5 true JP2013505011A5 (enExample) 2013-10-24

Family

ID=41277906

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012529337A Withdrawn JP2013505011A (ja) 2009-09-18 2010-09-16 幹細胞馴化培地組成物

Country Status (9)

Country Link
US (1) US20120207705A1 (enExample)
EP (1) EP2478091A1 (enExample)
JP (1) JP2013505011A (enExample)
KR (1) KR20120083407A (enExample)
CN (1) CN102712899A (enExample)
GB (1) GB0916370D0 (enExample)
IN (1) IN2012DN02443A (enExample)
SG (1) SG178914A1 (enExample)
WO (1) WO2011033260A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8728819B2 (en) 2006-08-29 2014-05-20 Fibrocell Technologies, Inc. Methods for culturing minimally-passaged fibroblasts and uses thereof
US9446075B2 (en) * 2011-05-06 2016-09-20 Bioregenerative Sciences Compositions derived from stem cell released molecules and methods for formulation thereof
CA2866563A1 (en) * 2012-03-07 2013-09-12 Fibrocell Technologies, Inc. Topical dermal formulations and methods of personalized treatment of skin
US9545370B2 (en) 2012-05-08 2017-01-17 BioRegenerative Sciences, Inc. Bioactive compositions and methods for their preparation and use
JP6041199B2 (ja) * 2012-09-14 2016-12-07 国立大学法人大阪大学 三次元細胞培養体の製造方法
CN103333856B (zh) * 2013-07-25 2015-08-26 张潇潇 人脐带间充质干细胞培养基
US9585915B2 (en) 2014-01-23 2017-03-07 Emory University Polypeptide hydrogels and uses related thereto
WO2016006885A1 (ko) * 2014-07-07 2016-01-14 메디포스트(주) 자극된 줄기세포 배양액의 발모 촉진능 및 이의 용도
RU2644650C2 (ru) 2014-12-01 2018-02-13 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток и способ его получения
US9944894B2 (en) 2015-01-16 2018-04-17 General Electric Company Pluripotent stem cell expansion and passage using a rocking platform bioreactor
CN105250994A (zh) * 2015-10-29 2016-01-20 广州赛莱拉干细胞科技股份有限公司 一种促进皮肤伤口愈合的制剂及其制备方法和应用
KR101928488B1 (ko) * 2016-01-15 2018-12-12 가톨릭대학교 산학협력단 페록시다신을 포함하는 무혈청 배지 첨가제 조성물 및 이의 이용
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
US11684574B2 (en) 2016-06-30 2023-06-27 University of Pittsburgh—of the Commonwealth System of Higher Education Artificial cells and delivery devices for use in tissue engineering, and related methods
JP2018023343A (ja) * 2016-08-12 2018-02-15 国立大学法人山口大学 細胞培養用培地、及び細胞培養方法
WO2018179374A1 (ja) * 2017-03-31 2018-10-04 株式会社セルバンク 真皮線維芽細胞の培養上清液を含む化粧用組成物およびその製造方法
JP7204730B2 (ja) * 2017-03-31 2023-01-16 セラム バイオメディカル， インコーポレイテッド 生体適合性馴化細胞培地組成物およびその使用
MY199879A (en) * 2017-10-03 2023-11-27 Univ Kebangsaan Malaysia Dermal fibroblast conditioned sera based on fibroblast-specific medium for skin regeneration
EP3569698A1 (en) 2018-05-16 2019-11-20 Veterinärmedizinische Universität Wien Products for therapy of a musculoskeletal condition and methods for their production
IL272145A (en) * 2020-01-20 2021-07-29 Stem Cell Medicine Ltd Cosmetic preparations with protein concentrate from a conditioned growth medium of stem cells from adipose tissue
CN113396894A (zh) * 2021-07-06 2021-09-17 南方医科大学南方医院 适用于单位毛囊保存的复合冻存液及其制备方法和应用
CN114107188B (zh) * 2021-11-30 2025-01-14 滨州医学院 一种干细胞成膜培养基及其应用
BR102022016233A2 (pt) * 2022-08-16 2024-02-27 Omics Biotecnologia Animal Ltda Concentrado de proteínas e peptídeos derivados de células estromais mesenquimais, método de obtenção e uso de concentrado

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708692D0 (en) 1997-04-30 1997-06-18 Jahoda Colin A B Dermal sheath tissue and/or cells derived therefrom in wound healing
US6372494B1 (en) 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
CA2452865A1 (en) 2001-06-07 2002-12-12 Skinmedica, Inc. Conditioned cell culture media and uses thereof
CA2958146C (en) * 2002-11-14 2019-08-20 Aderans Research Institute, Inc. Cultivation of hair inductive cells
HU227723B1 (en) * 2004-07-09 2012-01-30 Nagy Norbert Dr Autologous keratinocytes, melanocytes and fibroblast culturing technique and serum-free medium for use in human therapy
JP2010500047A (ja) 2006-08-15 2010-01-07 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 間葉系幹細胞馴化培地
GB0814443D0 (en) * 2008-08-07 2008-09-10 Avecia Biolog Ltd Process for cultivating cells

Similar Documents

Publication Publication Date Title
JP2013505011A5 (enExample)
JP2018512440A5 (enExample)
CN104082277B (zh) 一种人外周血单个核细胞的冻存保护剂及保存方法
JP2010519251A5 (enExample)
JP2018522593A5 (enExample)
CN108721200A (zh) 一种人间充质干细胞来源的外泌体美容制剂的制备方法及应用
JP2014523238A5 (enExample)
JP2009538871A5 (enExample)
RU2013119415A (ru) Способ получения поксвирусов и композиции поксвирусов
JP2010518833A5 (enExample)
HRP20151145T1 (hr) Fosfolipidima obogaä†ene vezikule koje nose tkivni faktor s hemostatskom aktivnosti i njihove uporabe
JP2016501013A5 (enExample)
JP2018512440A (ja) 皮膚細胞に対する若返り活性および／または創傷治癒活性を有する無細胞植物細胞培養懸濁液上清
Arai et al. Effect of pore size of honeycomb films on the morphology, adhesion and cytoskeletal organization of cardiac myocytes
EP3210611A3 (en) Methods of treating vascular inflammatory disorders
JP2013507934A5 (enExample)
CN104587528A (zh) 人心脏瓣膜组织脱细胞基质及其制备和应用
CN104292497A (zh) 一种重组人源胶原蛋白生物海绵的制备方法
JP2015534809A5 (enExample)
JP2019052182A5 (enExample)
Chen et al. A quick and innovative pipeline for producing chondrocyte-homing peptide-modified extracellular vesicles by three-dimensional dynamic culture of hADSCs spheroids to modulate the fate of remaining ear chondrocytes in the M1 macrophage-infiltrated microenvironment
JP2014523252A5 (enExample)
JP2011503008A5 (enExample)
CN103435837B (zh) 一种重组人源胶原蛋白生物海绵的制备方法
CN107137757A (zh) 一种rgd噬菌体/丝素复合止血材料及其制备方法